Introduction
Fucosidosis, first described by Durand et al., in 1966 , is an autosomal recessive lysosomal storage disease resulting from a deficiency of α-L-fucosidase (EC 3.2.1.51). Most fucosidosis patients have slow neurological deterioration, surviving to only their second or third decade (Willems et al. 1991; Thomas and Beaudet 1995) , but several patients, including the original ones, had rapid progressive neurological deterioration, leading to decerebration and death with 29.1 Ϯ 4.7 nmol/h per mg protein in control). At 4 age years, angiokeratoma appeared on her palms. Her bone abnormalities and motor dysfunction gradually progressed, until, at age 6 years, she was unable to walk. She also developed myoclonic seizures. At age 13 years, she showed spasticity and dystonia of all extremities with involuntary movements. She developed generalized angiokeratoma corporis diffusum, but showed no hepatosplenomegaly or pubertal development.
Subjects and methods
Mutation analysis. Genomic DNA was isolated from peripheral blood leukocytes of the patient and her parents by standard methods. All eight exons of FUCA1 were amplified from genomic DNA by PCR methods, using primer sets (Seo et al. 1993a ). The amplified products were purified and directly sequenced by Dye Terminator Cycle Sequencing Ready Reaction (ABI 310 Genetic Analyzer, Perkin-Elmer, Foster City, CA, USA). To confirm the mutation identified in the patient, the PCR products of exon 2 were digested with BsrI and subjected to 3% NuSieve (FMC Bio Products, Rockland, ME, USA) agarose gel electrophoresis.
Southern and Northern blot analysis. Fifteen micrograms of genomic DNA from the patient, the parents and normal individuals were digested with the restriction enzymes EcoRI, BamHI, or HindIII. Southern blot analysis was performed according to standard procedures. Hybridization probes were PCR-amplified from genomic DNA. Total RNA from cultured skin fibroblasts of the patient and normal individuals were isolated by a guanidium thiocyanatephenol-chloroform method, and 20 µg of RNA was used for Northern blot analyses. α-L-Fucosidase and -actin cDNA were radiolabelled, and hybridized using standard methods.
Fluorescence in situ hybridization (FISH) analysis.
Metaphase chromosomes of the patient and her mother were prepared. Cosmid probes containing exons 1-8 of FUCA1 were cloned from a genomic library of normal lymphocytes and labeled with biotin-16-dUTP. A chromosome Fig. 1a , b. Direct sequence analyses of FUCA1 genomic DNA and restriction enzyme analyses in the exon 2 region in genomic DNA. a Direct sequence analysis of the exon 2 region showed homozygous amino acids of codon 148 (TGA) in the patient, but heterozygous amino acids (TGG and TGA) in her father, and homozygous amino acids of the codon (TGG) in her mother. b In the normal sequence the genomic amplified PCR products containing two sites of BsrI were digested to 117-bp, 105-bp, and 24-bp products with Bsr I, and two bands, of 117-and 105 bp, were visible on 3% NuSieve agarose gel electrophoresis (upper panel and lane 3 in lower panel) (FMC Bio Products, Rockland, ME, USA). When there was the transition of G to A at codon 148, one site of BsrI was lost resulting in 141-bp and 105-bp products produced after BsrI digestion (upper panel and lane 2 in lower panel). In the patient, only the 141-bp and 105-bp products were detected, which showed homozygous mutations at the codon 148 (lane 2 in lower panel). The mother showed a normal pattern and the father showed a heterozygous pattern (lanes 3 and 4 in the lower panel, respectively). These results are compatible with the direct sequence analysis shown in a position (nucleotide number 444 of cDNA) showed that her father was heterozygous for the mutation and that her mother had no mutation. To explain this result, a deletion in the patient's and mother's genome at that poisition was considered. However, Southern blot analyses of the patient, her parents, and the control showed the same patterns as those in the restriction enzymatic digestion studies using a FUCA1 cDNA probe. From this evidence, a large deletion, including the whole FUCA1 gene, was suspected. To confirm this evidence, FISH analysis was performed, using a cosmid genomic clone containing the whole FUCA1 gene. The patient and her mother showed only one signal in chromosome 1 from the FISH study. It was concluded that the patient has the nonsense mutation from a paternal allele and the large deletion from a maternal allele.
To date, 25 mutations, including our patient's mutations, have been reported; 8 types of nonsense mutations, 5 types of missense mutations, 8 types of frame-shift mutations, 2 types of insertion, and 2 types of deletions (Yang et al. 1992; Seo et al. 1993a, b; Williamson et al. 1993; Yang et al. 1993; Seo et al. 1994a, b; Yang and DiCioccio 1994; Seo et al. 1995 , Seo et al. 1996 , Cragg et al. 1997 , Fleming et al. 1998 . Most mutations are unique, yet one mutation (Q77X) was repeatedly observed (Yang et al. 1993; Seo et al. 1993b) . Of the 25 known mutations, only 5 yield amino acid substitutions, whereas the other 20 are presumed to result in unstable or defective mRNA, similar to findings in our patient. This evidence is unique compared with findings in other lysosomal storage diseases. The clinical spectrum of this disease is very wide, and the coexistence of types I and II within the same family has been reported, while identical mutations have been identified in the homozygous state in patients (Willems et al. 1988 ). At the protein biochemical level, no heterogeneity was observed (Willems et al. 1991) . Our patient had no residual activity of α-L-fucosidase, as reported in most patients (Willems et al. 1991) . From the mutation and biochemical analysis, it seems that fucosidosis is homogeneous, despite the clinical variations. Most likely, modifying genes or environmental effects, which are currently unknown, are operative in fucosidosis. 
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Results
Mutation analysis. DNA sequence analyses revealed that the patient had a G-to-A transition at cDNA nucleotide number 444 in exon 2, resulting in Trp to stop codon at codon 148 (TGG to TGA, designated W148X). Her father was found to be heterozygous (G/A) for the W148X mutation. However, the mother had a normal sequence (Fig. 1a) .
To confirm this evidence, restriction site analyses of genomic DNA were performed. The W148X mutation obliterates a BsrI site. In the presence of BsrI sites, the 246-bp PCR product of exon 2 was digested into 117-, 105-, and 24-bp, but fragments of 141-bp and 105-bp were obtained with the mutation. In the father, 141-, 117-, and 105-bp fragments were obtained. However, 141-bp and 105-bp fragments were obtained in the patient, and 117-bp and 105-bp fragments were obtained in the mother (Fig. 1b) . These data show that one allele has the W148X mutation and the other has a deletion at that position in the patient. Therefore, her father is a carrier for the W148X mutation and her mother probably has a deletion.
Southern and Northern blot analysis. Southern blot analyses of genomic DNA of the patient and her parents, digested with EcoRI, BamHI, or HindIII, showed no differences among them, suggesting a large deletion in the patient and her mother (data not shown). Northern blot analyses from lymphoid cells of a healthy individual showed a band of 2.3 kb, but no band could be detected in the patient (data not shown).
Fluorescence in situ hybridization analysis. Fluorescence in situ hybridization analyses of lymphocytes from the patient and her mother showed only one signal of FUCA1 (Fig. 2 , red color).
Discussion
We have described a patient with late infantile onset fucosidosis with slow progressive symptoms, considered to be an intermediate form between types I and II. We identified a new mutation, W148X, and a large deletion, including all exons, of the FUCA1 gene. From DNA sequence analyses of amplified PCR products of exon 2 in the patient, homozygosity for the W148X mutation was considered. However, genomic DNA analyses of her parents at that 
